Dr. Jack Wu is the Senior Director of Search & Evaluation at Takeda Oncology, where he is responsible for driving the assessment of late-stage business development opportunities in alignment with Takeda Oncology’s BD strategy and integrated Disease Area Strategies. He also collaborates on the development and execution of Takeda’s global oncology business development strategy. Previously, he led Global Business Development at Antengene, securing over 15 strategic partnerships with companies such as Merck and Bristol Myers Squibb. Before that, he served as the US Head of Business Development at Adlai Nortye USA Inc., managing collaborations with Novartis, Merck, and Eisai. His additional experience includes business development executive roles at ATCC and GenScript. Dr. Wu holds an MBA from Columbia University and a PhD from North Carolina State University.